| Market Capitalization (Millions $) |
16,884 |
| Shares
Outstanding (Millions) |
29 |
| Employees |
6,200 |
| Revenues (TTM) (Millions $) |
2,782 |
| Net Income (TTM) (Millions $) |
492 |
| Cash Flow (TTM) (Millions $) |
606 |
| Capital Exp. (TTM) (Millions $) |
46 |
Business Description
Medpace Holdings Inc. is a global contract research organization (CRO) that provides full-service clinical development solutions to its clients in the biopharmaceutical and medical device industries. Headquartered in Cincinnati, Ohio, the company was founded in 1992 by Dr. August Troendle, who still serves as its Chief Executive Officer.
Medpace offers a comprehensive range of clinical research services, including study design, protocol development, site identification and management, data management, biostatistics, regulatory affairs, clinical monitoring, medical writing, pharmacovigilance, and medical affairs. The company has specialized expertise in areas such as oncology, cardiology, neuroscience, infectious diseases, and rare diseases.
The company operates in over 45 countries and has a workforce of over 4,000 employees, including more than 1,200 medical personnel. Medpace has a proven track record of delivering high-quality clinical trials on time and within budget. As a result, it has established long-term partnerships with over 500 clients, ranging from small biotech startups to large pharmaceutical companies.
Medpace's quality management system is based on the principles of ICH Good Clinical Practice (GCP) and ISO 9001:2015. The company has been audited and inspected by regulatory authorities around the world, including the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA).
Medpace went public in 2016, raising $172.5 million in its initial public offering (IPO) on the NASDAQ stock exchange. Since then, the company's stock has steadily grown, reflecting the company's strong financial performance and growth prospects.
In summary, Medpace Holdings Inc. is a leading global CRO that provides full-service clinical development solutions to its clients in the biopharmaceutical and medical device industries. With a proven track record, specialized expertise, and a commitment to quality, Medpace is well-positioned to meet the increasing demand for clinical trial services in the healthcare industry.
Company Address: 5375 Medpace Way Cincinnati 45227 OH
Company Phone Number: 579-9911 Stock Exchange / Ticker: NASDAQ MEDP
|
199.9 %